NDRA

ENDRA Life Sciences Inc. NDRA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$819.0K total
Altium Capital Management LP
$315.9K+14.2%
CITADEL ADVISORS LLC
$159.5KNew
CITIZENS FINANCIAL GROUP INC/RI
$151.4KNew
GEODE CAPITAL MANAGEMENT, LLC
$79.5K-29.3%
VANGUARD FIDUCIARY TRUST CO
$53.9K0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$39.1K+160.6%
MORGAN STANLEY
$18.9K0.0%
UBS Group AG
$362-55.3%
Tower Research Capital LLC (TRC)
$309New
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
$1010.0%
See all 10 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NDRA

Earnings Per Share

13fpro.ai/company/NDRA

Loading ratio trend…

NDRA key financials by period

Reported revenue, net income and operating margin by fiscal year, from ENDRA Life Sciences Inc.'s annual filings on SEC EDGAR.

ENDRA Life Sciences Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2018$6.2K$-9.8M—
FY 2017$351.6K$-5.4M—
FY 2016$515.6K$-2.8M—
Source: NDRA filings on SEC EDGAR →

NDRA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About ENDRA Life Sciences Inc. (NDRA): stock profile, AI score and financials

ENDRA Life Sciences Inc. (NDRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NDRA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.5m in revenue and is scored on the micro-cap board instead. Top institutional holders of NDRA by reported 13-F value include Altium Capital Management, CITADEL ADVISORS, CITIZENS FINANCIAL GROUP, based on the most recent SEC filings. NDRA trades on the Nasdaq exchange and files with the SEC under CIK 1681682. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NDRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ENDRA Life Sciences Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1681682 →